Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2010
05/27/2010WO2010033866A3 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
05/27/2010WO2010026473A3 Pta072 protein
05/27/2010WO2010007376A3 Compositions monovalent for cd28 binding and methods of use
05/27/2010WO2010006286A3 Constructs and libraries comprising antibody surrogate kappa light chain sequences
05/27/2010WO2010005567A3 Notch1 receptor binding agents and methods of use thereof
05/27/2010WO2010002862A3 Fibroblast growth factor receptor 3 (fgfr3) binding proteins
05/27/2010WO2009155504A3 Methods for the modulation of angiogenesis
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100132056 Germ Cell Marker Using Fish Vasa Gene
05/27/2010US20100131432 Methods and compositions of molecular profiling for disease diagnostics
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130728 Taci-immunoglobulin fusion proteins
05/27/2010US20100130727 an eluant containing an organic-solvent is used at a first pH to remove non-target solutes and suspended entities from an affinity chromatography column, the pH of the eluant is then changed to a second pH, and the organic-solvent-containing eluant is used to elute target molecules from the column
05/27/2010US20100130590 Deletion bearing bard1 isoforms and use thereof
05/27/2010US20100130429 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
05/27/2010US20100130424 Crhr2 peptide agonists and uses thereof
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100129931 Anti-Methylation-Controlled J Protein Antibodies and Uses Thereof
05/27/2010US20100129930 Tyrosine Phosphorylation Sites
05/27/2010US20100129929 Tyrosine Phosphorylation Sites
05/27/2010US20100129928 Tyrosine Phosphorylation Sites
05/27/2010US20100129905 Mammalian cytokines; related reagents and methods
05/27/2010US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
05/27/2010US20100129841 Detection of a blood coagulation activity marker in a body fluid sample
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129807 Stabilization of cyclic peptide structures
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
05/27/2010US20100129384 Taci-immunoglobulin fusion proteins
05/27/2010US20100129383 Bifunctional fusion molecules for the delivery of antigens to professional antigen-presenting cells
05/27/2010US20100129380 Antibodies Against IL-25
05/27/2010US20100129377 Milk derived antigen-specific antibodies, methods of preparation and uses thereof
05/27/2010US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129373 Vegf-specific human antibody
05/27/2010US20100129372 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
05/27/2010US20100129369 c-Met Antibodies
05/27/2010US20100129368 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof
05/27/2010US20100129367 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
05/27/2010US20100129360 Antibodies against human interleukin-13 and uses therefor
05/27/2010US20100129355 Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
05/27/2010US20100129349 Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
05/27/2010US20100129347 Herpes virus infection inhibitor, method for inhibiting infection with herpes virus, and use thereof
05/27/2010US20100129346 Anti-C5aR Antibodies With Improved Properties
05/27/2010US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses
05/27/2010US20100129315 Anti-MN Antibodies and Methods of Using Same
05/27/2010US20100129314 Potent conjugates and hydrophilic linkers
05/27/2010US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same
05/27/2010CA2744405A1 Bispecific egfr/igfir binding molecules
05/27/2010CA2743508A1 C-met antibodies
05/27/2010CA2743012A1 Rsv f vlps and methods of manufacture and use thereof
05/27/2010CA2742792A1 Prediction and prevention of preeclampsia
05/26/2010EP2189526A1 Antibody binding specifically to tdp-43 aggregate
05/26/2010EP2189523A1 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189471A1 Foxm1 peptide and medicinal agent comprising the same
05/26/2010EP2189470A1 Tumor antigens
05/26/2010EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
05/26/2010EP2188313A1 Human c-fms antigen binding proteins
05/26/2010EP2188312A2 Novel antibodies inhibiting c-met dimerization, and uses thereof
05/26/2010EP2188310A1 Humanized anti-fgf19 antagonists and methods using same
05/26/2010EP2188309A1 Gelsolin binding agent compositions and uses of same
05/26/2010EP2188306A1 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
05/26/2010EP2187964A1 High affinity human antibodies to human nerve growth factor
05/26/2010EP1718737B1 Cancerous disease modifying antibodies
05/26/2010EP1653915B1 Prkcs as modifiers of the beta catenin pathway and methods of use
05/26/2010EP1613345B1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
05/26/2010EP1596809B1 Abeta binding molecules
05/26/2010EP1448602B1 Modified anti-tnf alpha antibody
05/26/2010EP1307225B1 Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions
05/26/2010EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/26/2010EP1037916B1 Erythrovirus and its applications
05/26/2010CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
05/26/2010CN1845938B Polypeptides
05/26/2010CN1723219B Protein complex using immunoglobulin fragment and method for the preparation thereof
05/26/2010CN1711282B Inhibition of Il-17 production
05/26/2010CN1711279B Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor
05/26/2010CN1680426B Purification method which prevents denaturation of an antibody
05/26/2010CN1678744B Human antihuman interleukin-6 antibody and fragment of the antibody
05/26/2010CN1671412B Immunostimulatory compositions and methods of stimulating an immune response
05/26/2010CN1668637B Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
05/26/2010CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/26/2010CN1596313B Humanized collagen antibodies and related methods
05/26/2010CN1555384B Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination
05/26/2010CN1518458B Graft rejection inhibitors
05/26/2010CN1468308B Anti-TNF antibodies, compositions, methods and uses
05/26/2010CN1425066B Novel stra6 polypeptides
05/26/2010CN101715456A Milk derived antigen specific antibodies, methods of preparation and uses thereof
05/26/2010CN101715348A A new immunoglobulin against helicobacter pylori
05/26/2010CN101712960A Mac-2BP tumor antigen gene, protein, antibody and application thereof
05/26/2010CN101712959A Novel human cell growth inhibiting gene THAP11 and application thereof
05/26/2010CN101712958A Novel human tumor inhibiting gene KIAA0157 and application thereof
05/26/2010CN101712722A Glp-1 fusion proteins
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712719A Preparation method and application of humanized neutralized anti-influenza NS1 genetic engineering antibody
05/26/2010CN101711868A Gene detection assay for improving the likelihood of an effective response to a ErbB antibody cancer therapy
05/26/2010CN101711866A Method for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies
05/26/2010CN101711861A bacterial virulence factors and uses thereof
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 1494